Bioventix PLC (LON:BVXP – Get Free Report) announced a dividend on Monday, March 31st, DividendData.Co.Uk reports. Stockholders of record on Thursday, April 10th will be given a dividend of GBX 70 ($0.89) per share by the biotechnology company on Friday, April 25th. This represents a dividend yield of 2.95%. The ex-dividend date of this dividend is Thursday, April 10th. The official announcement can be seen at this link.
Bioventix Stock Up 1.5 %
Shares of LON BVXP opened at GBX 2,436 ($31.01) on Tuesday. The firm has a market cap of £127.56 million, a PE ratio of 15.75 and a beta of 0.35. The company’s fifty day simple moving average is GBX 2,819.35 and its 200 day simple moving average is GBX 3,310.18. Bioventix has a 12-month low of GBX 2,200 ($28.00) and a 12-month high of GBX 4,800 ($61.10).
Bioventix (LON:BVXP – Get Free Report) last issued its earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.92) EPS for the quarter. Bioventix had a return on equity of 69.09% and a net margin of 59.51%. On average, equities analysts predict that Bioventix will post 166.3066955 earnings per share for the current year.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Featured Articles
- Five stocks we like better than Bioventix
- How to Use the MarketBeat Dividend Calculator
- Progress Software: Making Progress Driven by the AI Revolution
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Intel-Taiwan Semiconductor Alliance Fuels Turnaround Hopes
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Buffett’s Next Oil Bet: Why Occidental Is Different
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.